Hikal's Stock Sees 5.34% Increase, Rated 'Hold' by MarketsMOJO
Hikal, a midcap pharmaceutical and drug company, saw a 5.34% increase in its stock price on November 14, 2024. According to MarketsMojo, the stock is currently rated as 'Hold', indicating a positive but cautious outlook. The stock has consistently performed well, trading higher than its moving averages and outperforming the market.
Hikal, a midcap pharmaceutical and drug company, saw a 5.34% increase in its stock price on November 14, 2024. This rise was in line with the overall positive performance of the company in recent months.
According to MarketsMOJO, a leading stock analysis platform, Hikal's stock is currently rated as 'Hold'. This indicates that while the company's performance has been positive, it may not be the best time to buy or sell the stock.
The stock is currently trading close to its 52-week high of Rs 415.3, with a difference of only 2.29%. This shows that the company's stock has been consistently performing well in the market.
On the day of the increase, Hikal's stock touched an intraday high of Rs 406.75, which is a 5.02% increase from its previous closing price. This shows a strong performance by the company in the market.
Hikal's stock is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend in the company's stock performance.
In comparison to the overall market performance, Hikal's stock has outperformed the Sensex by 4.95% on the day of the increase. In the past month, the company's stock has also outperformed the Sensex by 12.00%.
Overall, Hikal's stock has shown a strong and consistent performance in the market, making it a promising investment option for investors. However, it is important to note that this is not a recommendation and investors should do their own research before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
